Experimental Hematology
Volume 38, Issue 5 , Pages 403-416 , May 2010

Runx1 isoforms show differential expression patterns during hematopoietic development but have similar functional effects in adult hematopoietic stem cells

  • Grant A. Challen

      Affiliations

    • Stem Cells and Regenerative Medicine Center, Baylor College of Medicine, Houston, Tex., USA
    • Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, Tex., USA
    • Department of Anatomy and Cell Biology, Monash University, Clayton, Victoria, Australia
    • ,
  • Margaret A. Goodell

      Affiliations

    • Stem Cells and Regenerative Medicine Center, Baylor College of Medicine, Houston, Tex., USA
    • Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, Tex., USA
    • Department of Pediatrics, Baylor College of Medicine, Houston, Tex., USA
    • Corresponding Author InformationOffprint requests to: Margaret A. Goodell, Ph.D., Stem Cells and Regenerative Medicine Center, Baylor College of Medicine, 1 Baylor Plaza, Houston, TX 77030

Received 13 November 2009 ,Revised 25 February 2010 ,Accepted 25 February 2010.

References 

  1. Look AT. Oncogenic transcription factors in the human acute leukemias. Science. 1997;278:1059–1064
  2. Speck NA, Gilliland DG. Core-binding factors in haematopoiesis and leukaemia. Nat Rev. Cancer. 2002;2:502–513
  3. Okuda T, van Deursen J, Hiebert SW, Grosveld G, Downing JR. AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell. 1996;84:321–330
  4. Wang Q, Stacy T, Binder M, Marin-Padilla M, Sharpe AH, Speck NA. Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis. Proc Natl Acad Sci U S A. 1996;93:3444–3449
  5. Okada H, Watanabe T, Niki M, et al. AML1(-/-) embryos do not express certain hematopoiesis-related gene transcripts including those of the PU.1 gene. Oncogene. 1998;17:2287–2293
  6. North TE, de Bruijn MF, Stacy T, et al. Runx1 expression marks long-term repopulating hematopoietic stem cells in the midgestation mouse embryo. Immunity. 2002;16:661–672
  7. North T, Gu TL, Stacy T, et al. Cbfa2 is required for the formation of intra-aortic hematopoietic clusters. Development. 1999;126:2563–2575
  8. Yokomizo T, Ogawa M, Osato M, et al. Requirement of Runx1/AML1/PEBP2alphaB for the generation of haematopoietic cells from endothelial cells. Genes Cells. 2001;6:13–23
  9. Ichikawa M, Asai T, Saito T, et al. AML-1 is required for megakaryocytic maturation and lymphocytic differentiation, but not for maintenance of hematopoietic stem cells in adult hematopoiesis. Nat Med. 2004;10:299–304
  10. Growney JD, Shigematsu H, Li Z, et al. Loss of Runx1 perturbs adult hematopoiesis and is associated with a myeloproliferative phenotype. Blood. 2005;106:494–504
  11. Putz G, Rosner A, Nuesslein I, Schmitz N, Buchholz F. AML1 deletion in adult mice causes splenomegaly and lymphomas. Oncogene. 2006;25:929–939
  12. Fujita Y, Nishimura M, Taniwaki M, Abe T, Okuda T. Identification of an alternatively spliced form of the mouse AML1/RUNX1 gene transcript AML1c and its expression in early hematopoietic development. Biochem Biophys Res Commun. 2001;281:1248–1255
  13. Ghozi MC, Bernstein Y, Negreanu V, Levanon D, Groner Y. Expression of the human acute myeloid leukemia gene AML1 is regulated by two promoter regions. Proc Natl Acad Sci U S A. 1996;93:1935–1940
  14. Miyoshi H, Ohira M, Shimizu K, et al. Alternative splicing and genomic structure of the AML1 gene involved in acute myeloid leukemia. Nucleic Acids Res. 1995;23:2762–2769
  15. Rennert J, Coffman JA, Mushegian AR, Robertson AJ. The evolution of Runx genes I. A comparative study of sequences from phylogenetically diverse model organisms. BMC Evol Biol. 2003;3:4
  16. Bangsow C, Rubins N, Glusman G, et al. The RUNX3 gene—sequence, structure and regulated expression. Gene. 2001;279:221–232
  17. Xiao ZS, Hjelmeland AB, Quarles LD. Selective deficiency of the "bone-related" Runx2-II unexpectedly preserves osteoblast-mediated skeletogenesis. J Biol Chem. 2004;279:20307–20313
  18. Zambidis ET, Peault B, Park TS, Bunz F, Civin CI. Hematopoietic differentiation of human embryonic stem cells progresses through sequential hematoendothelial, primitive, and definitive stages resembling human yolk sac development. Blood. 2005;106:860–870
  19. Goodell MA, Brose K, Paradis G, Conner AS, Mulligan RC. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J Exp Med. 1996;183:1797–1806
  20. Challen GA, Martinez G, Davis MJ, et al. Identifying the molecular phenotype of renal progenitor cells. J Am Soc Nephrol. 2004;15:2344–2357
  21. Challen G, Gardiner B, Caruana G, et al. Temporal and spatial transcriptional programs in murine kidney development. Physiol Genomics. 2005;23:159–171
  22. Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al. Embryonic stem cell lines derived from human blastocysts. Science. 1998;282:1145–1147
  23. Naviaux RK, Costanzi E, Haas M, Verma IM. The pCL vector system: rapid production of helper-free, high-titer, recombinant retroviruses. J Virol. 1996;70:5701–5705
  24. Kotani H, Newton PB, Zhang S, et al. Improved methods of retroviral vector transduction and production for gene therapy. Hum Gene Ther. 1994;5:19–28
  25. Challen GA, Boles N, Lin KK, Goodell MA. Mouse hematopoietic stem cell identification and analysis. Cytometry A. 2009;75:14–24
  26. Baines P, Bol SJ, Rosendaal M. Physical and kinetic properties of haemopoietic progenitor cell populations from mouse marrow detected in five different assay systems. Leuk Res. 1982;6:81–88
  27. Bartelmez SH, Andrews RG, Bernstein ID. Uncovering the heterogeneity of hematopoietic repopulating cells. Exp Hematol. 1991;19:861–862
  28. Bearpark AD, Gordon MY. Adhesive properties distinguish sub-populations of haemopoietic stem cells with different spleen colony-forming and marrow repopulating capacities. Bone Marrow Transplant. 1989;4:625–628
  29. Curry JL, Trentin JJ. Hemopoietic spleen colony studies. I. Growth and differentiation. Dev Biol. 1967;15:395–413
  30. Harris RA, Hogarth PM, Wadeson LJ, Collins P, McKenzie IF, Penington DG. An antigenic difference between cells forming early and late haematopoietic spleen colonies (CFU-S). Nature. 1984;307:638–641
  31. Molineux G, Schofield R, Testa NG. Development of spleen CFU-S colonies from day 8 to day 11: relationship to self-renewal capacity. Exp Hematol. 1986;14:710–713
  32. Ploemacher RE, Brons RH. Separation of CFU-S from primitive cells responsible for reconstitution of the bone marrow hemopoietic stem cell compartment following irradiation: evidence for a pre-CFU-S cell. Exp Hematol. 1989;17:263–266
  33. Burns CE, Traver D, Mayhall E, Shepard JL, Zon LI. Hematopoietic stem cell fate is established by the Notch-Runx pathway. Genes Dev. 2005;19:2331–2342
  34. Yu X, Alder JK, Chun JH, et al. HES1 inhibits cycling of hematopoietic progenitor cells via DNA binding. Stem Cells. 2006;24:876–888
  35. Santaguida M, Schepers K, King B, et al. JunB protects against myeloid malignancies by limiting hematopoietic stem cell proliferation and differentiation without affecting self-renewal. Cancer Cell. 2009;15:341–352
  36. Bee T, Liddiard K, Swiers G, et al. Alternative Runx1 promoter usage in mouse developmental hematopoiesis. Blood Cells Mol Dis. 2009;43:35–42
  37. Pozner A, Lotem J, Xiao C, et al. Developmentally regulated promoter-switch transcriptionally controls Runx1 function during embryonic hematopoiesis. BMC Dev Biol. 2007;7:84
  38. Tsuzuki S, Hong D, Gupta R, Matsuo K, Seto M, Enver T. Isoform-specific potentiation of stem and progenitor cell engraftment by AML1/RUNX1. PLoS Med. 2007;4:e172
  39. Cao W, Britos-Bray M, Claxton DF, et al. CBF beta-SMMHC, expressed in M4Eo AML, reduced CBF DNA-binding and inhibited the G1 to S cell cycle transition at the restriction point in myeloid and lymphoid cells. Oncogene. 1997;15:1315–1327
  40. Ichikawa M, Goyama S, Asai T, et al. AML1/Runx1 negatively regulates quiescent hematopoietic stem cells in adult hematopoiesis. J Immunol. 2008;180:4402–4408
  41. Maillard I, Koch U, Dumortier A, et al. Canonical notch signaling is dispensable for the maintenance of adult hematopoietic stem cells. Cell Stem Cell. 2008;2:356–366
  42. Stier S, Cheng T, Dombkowski D, Carlesso N, Scadden DT. Notch1 activation increases hematopoietic stem cell self-renewal in vivo and favors lymphoid over myeloid lineage outcome. Blood. 2002;99:2369–2378

PII: S0301-472X(10)00076-7

doi: 10.1016/j.exphem.2010.02.011

Experimental Hematology
Volume 38, Issue 5 , Pages 403-416 , May 2010

Article Tools

* Image Usage & Resolution